ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,764Medicare Part D Prescriptions Filled, Including Refills

Rank: 302 out of 6645

$917K Total Retail Price of All Prescriptions

Rank: 388 out of 6645

527 Patients Receiving at Least One Drug in Part D
41%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 527 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

70% of this provider’s 527 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

9% of this provider’s 7,246 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 2,194 921 S3 1 5
CARISOPRODOL 1,173 349 R 2 94
AMOXICILLIN 503 222 3 107
ZOLPIDEM TARTRATE 420 185 4 17
OXYCODONE HCL 375 161 S2 5 162
AMLODIPINE BESYLATE 365 171 6 2
LISINOPRIL 339 187 7 3
IBUPROFEN 301 111 8 42
METFORMIN HCL 283 119 9 7
OMEPRAZOLE 272 134 10 6
ACETAMINOPHEN-CODEINE 269 132 S3 11 80
CEPHALEXIN 236 122 12 111
AZITHROMYCIN 224 119 13 44
GABAPENTIN 219 47 14 18
LEVOTHYROXINE SODIUM 200 138 15 4
ATORVASTATIN CALCIUM 197 103 16 10
TAMSULOSIN HCL 187 151 17 22
SIMVASTATIN 182 96 18 1
PROAIR HFA 181 75 19 32
TRIAMTERENE-HCTZ 178 95 20 52
TRAMADOL HCL 161 67 21 30
KLOR-CON 8 143 77 22 123
SULFAMETHOXAZOLE-TRIMETHOPRIM 141 57 23 134
FUROSEMIDE 136 79 24 11
SINGULAIR 131 54 25 76
ALLOPURINOL 131 99 25 31
XOPENEX HFA 130 77 27 345
NEXIUM 119 43 28 40
ATENOLOL 117 61 29 8
GLYBURIDE 108 71 R 30 58
LIPITOR 107 28 31 69
TRAZODONE HCL 105 62 32 60
VENTOLIN HFA 104 65 33 146
BENAZEPRIL HCL 101 52 34 21
OPANA ER 101 43 S2 34 504
METOPROLOL TARTRATE 99 61 36 13
CAPTOPRIL 97 52 37 221
CELEBREX 96 55 38 54
HYDROCHLOROTHIAZIDE 94 70 39 9
BACLOFEN 87 54 40 100
ADVAIR DISKUS 84 45 41 45
BUPROPION HCL SR 81 16 42 296
OXYCONTIN 80 37 S2 43 236
NITROSTAT 74 50 44 193
TRIAMCINOLONE ACETONIDE 74 45 44 55
FAMOTIDINE 73 20 46 33
INSULIN SYRINGE 72 33 47 61
QUETIAPINE FUMARATE 71 34 48 101
DONEPEZIL HCL 71 41 48 27
PANTOPRAZOLE SODIUM 71 36 48 29
CYCLOBENZAPRINE HCL 71 25 R 48 157
OXYCODONE HCL-ACETAMINOPHEN 68 0 S2 52 213
AMOX TR-POTASSIUM CLAVULANATE 67 21 53 185
PROCHLORPERAZINE MALEATE 67 26 53 347
NAPROXEN 67 21 53 88
DIGOXIN 65 64 56 59
CIPROFLOXACIN HCL 60 29 57 67
DEXILANT 59 25 58 102
CLONIDINE HCL 58 25 59 56
PLAVIX 56 26 60 49
ESTROPIPATE 55 13 R 61 719
COMBIVENT 55 15 61 174
DETROL LA 55 16 61 260
OLANZAPINE 54 26 64 140
AMITRIPTYLINE HCL 53 13 R 65 117
ACTOS 53 32 65 71
LANTUS 52 24 67 50
ALCOHOL SWABS 52 38 67 319
CARVEDILOL 51 15 69 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.